[HTML][HTML] Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and …
M Kovac, N Rathi, S Kuriyakose, K Hardt, TF Schwarz - Vaccine, 2015 - Elsevier
Background Pertussis in adults and adolescents could be reduced by replacing traditional
tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus …
tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus …
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)
M Knuf, V Vetter, F Celzo, G Ramakrishnan… - Human …, 2010 - Taylor & Francis
Background: The rising incidence of pertussis amongst adults and adolescents in
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …
Combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults
E Grimprel, F Von Sonnenburg, R Sänger, V Abitbol… - Vaccine, 2005 - Elsevier
Many countries recommend diphtheria, tetanus and/or poliomyelitis boosters in adolescents
or adults and the need for pertussis booster vaccination beyond childhood is increasingly …
or adults and the need for pertussis booster vaccination beyond childhood is increasingly …
Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria …
H Theeten, H Rümke, FJP Hoppener… - … medical research and …, 2007 - Taylor & Francis
Objective: To evaluate immunogenicity and reactogenicity of primary vaccination with
reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) or dTpa-inactivated …
reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) or dTpa-inactivated …
Booster vaccination of adults with reduced-antigen-content diphtheria, tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination
PB McIntyre, MA Burgess, A Egan, L Schuerman… - Vaccine, 2009 - Elsevier
At 60 months post-vaccination, adults (mean age 45.6 years) randomised to receive
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after …
M Kovac, L Kostanyan, N Mesaros… - Human Vaccines & …, 2018 - Taylor & Francis
Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …
increasing number of outbreaks have been observed over the last decades. The reduced …
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus …
R Dominicus, F Galtier, P Richard, M Baudin - Vaccine, 2014 - Elsevier
Introduction The immunogenicity and safety of one dose of Tdap-IPV (tetanus, diphtheria,
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …
Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age
R Vergara, M Tregnaghi, J Ussher, S Navarro… - European journal of …, 2005 - Springer
High rates of pertussis disease in adolescents suggest that additional boosting against
pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine …
pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine …
Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …
R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …
of booster doses in older children and adults. This can be conveniently accomplished by …
Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial
J Beytout, O Launay, N Guiso, A Fiquet, M Baudin… - Human …, 2009 - Taylor & Francis
Background: In France, the only vaccines available for use as a pertussis booster in adults
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …
相关搜索
- dtpa ipv antigen content
- diphtheria tetanus antigen content
- booster vaccination antigen content
- acellular pertussis antigen content
- polio vaccine antigen content
- dtpa ipv booster vaccination
- immunogenicity and reactogenicity antigen content
- immunogenicity and reactogenicity acellular pertussis
- dtpa ipv acellular pertussis
- dtpa ipv diphtheria tetanus
- poliovirus vaccines diphtheria tetanus
- dtpa ipv polio vaccine
- polio vaccine acellular pertussis
- booster dose acellular pertussis
- immunogenicity and reactogenicity booster dose
- polio vaccine booster vaccination